Indeed, mosquitoes treated with the MEK1/2 inhibitor PD98059 and human TGF-β1 showed higher NOS gene expression and evidence of lower infection intensity at low infection levels or oocyst loads, suggesting that MEK-ERK signaling negatively controls mosquito innate immunity and thus favors parasite development. This evidence concerns the gene MAP2K1 and infection.